Where does Academisch Medisch Centrum BIJ DE Universiteit VAN Amsterdam rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Academisch Medisch Centrum BIJ DE Universiteit VAN Amsterdam ranks #23,759 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Is Academisch Medisch Centrum BIJ DE Universiteit VAN Amsterdam's patent grant rate increasing or decreasing?

Academisch Medisch Centrum BIJ DE Universiteit VAN Amsterdam's recent grant velocity is -90% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Academisch Medisch Centrum BIJ DE Universiteit VAN Amsterdam's patents?

Academisch Medisch Centrum BIJ DE Universiteit VAN Amsterdam's patents average 12.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Academisch Medisch Centrum BIJ DE Universiteit VAN Amsterdam

Q: How is the Academisch Medisch Centrum BIJ DE Universiteit VAN Amsterdam patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 11 granted patents across 11 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Academisch ranks #23,759 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 11 technology areas.

#23,759
of 49,997 US assignees by volume: 25th percentile
by Innovation Score (27.8/100): 12.4
avg claims per patent: -90%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23759 · Foreign Corporation #23,759 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #23,759/49,997
PHOTO-FINISH A2 Biotherapeutics
CPC-FOCUS C07K · 11 areas
INNOV-THIN 27.8/100
CLAIMS-RICH 12.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -90% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: A2 Biotherapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Academisch’s 27.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (31%) Velocity 0.0 pts (0%) Breadth 11.7 pts (42%) Claim depth 7.5 pts (27%)

Qualcomm Incorporated · highest

85
Academisch Medisch… · this assignee

28
3D Lighting… · lowest

7

What this shows Academisch's Innovation Score is 27.8/100 (25th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Academisch?

Each dot is one of Academisch’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Academisch’s own 12.4 claims/patent is at or below the 18.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Academisch vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Academisch's grants concentrate

Academisch Medisch Centrum BIJ DE Universiteit VAN Amsterdam is a focused PatentsView assignee: 11 CPC subclasses with 72.7% of grants classified under C07K (Peptides). Peak complete grant year is 2015 (5 grants) versus a trough of 1 in 2018. By volume, Academisch sits between A2 Biotherapeutics, Inc. and Acqueon Technologies Inc..

A2 Biotherapeutics

11
AAC Optics (Nanni…

11
Abbott Japan

11
Abrado

11
Accurence

11
Accutec Blades

11
Acer Cloud Techno…

11
Acqueon

11
Academisch Medisc… ◀

11

What this shows Academisch holds 11 patents at rank #23,760, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Academisch

By rank, the assignees closest to #23,760 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Academisch's primary technology class.

Academisch's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 25th percentile higher than 25% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Academisch Medisch Centrum BIJ DE Universiteit VAN Amsterdam patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	45.5%
2017	3	27.3%
2018	1	9.1%
2019	1	9.1%
2020	1	9.1%

Which technologies does Academisch Medisch Centrum BIJ DE Universiteit VAN Amsterdam patent most?

C07K - Peptides 8

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 7

A61B - DIAGNOSIS; SURGERY; Identification 3

H05G - X-ray Technique 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 1

G01G - Weighing 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

C07D - Heterocyclic Compounds 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Academisch Medisch Centrum BIJ DE Universiteit VAN Amsterdam's patent record in context - here's where to go next.

Academisch Medisch Centrum BIJ DE Universiteit VAN Amsterdam's lead technology class is C07K (Peptides), 72.7% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #23,759 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Academisch Medisch Centrum BIJ DE Universiteit VAN Amsterdam against A2 Biotherapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.